Table 2.
Description of the development phase and funding sources of the apps.
| Reference | Quality of design and evaluation phase | Health care provider involvement | Patient involvement | Qualitative phase | Funding/development |
| Li et al, 2017 [16] | N/Aa | N/A | N/A | N/A | Private |
| Skrepnik et al, 2017 [17] | Bb | −c | +d | − | Private |
| Kristjansdottir et al, 2013 [18] | Ae | − | + | + | Public |
| Kristjansdottir et al, 2013 [19] | A | − | + | + | Public |
| Paxton et al, 2018 [20] | B | − | + | − | Private |
| Harmelink et al, 2017 [21] | B | − | + | − | Private |
| Bults et al, 2010 [22] | B | − | + | − | Public |
| Kvien et al, 2005 [23] | B | − | + | − | Public |
| Heiberg et al, 2007 [24] | B | − | + | − | Not reported |
| Richter et al, 2008 [25] | B | + | + | − | Public |
| Stinson et al, 2008 [26] | A | + | + | + | Public |
| Stinson et al, 2006 [27] | A | + | + | + | Public |
| Garcia-Palacios et al, 2014 [28] | B | + | + | − | Public |
| Nishiguchi et al, 2016 [29] | B | − | + | − | Public |
| de la Vega et al, 2018 [30] | A | + | + | + | Public |
| Salaffi et al, 2013 [31] | B | − | + | − | Private |
| Yen et al, 2016 [32] | B | + | + | − | Public |
| Khurana et al, 2016 [33] | A | − | + | + | Private |
| Kim et al, 2016 [34] | B | − | + | − | Public |
| Cai et al, 2017 [35] | A | + | + | + | Public |
| Revenas et al, 2015 [36] | A | + | + | + | Public and private |
| Synnott et al, 2015 [37] | B | + | + | − | Public |
| Bromberg et al, 2016 [38] | B | − | + | − | Public |
| Bromberg et al, 2014 [39] | B | − | + | − | Public |
| Okifuji et al, 2011 [40] | B | − | + | − | Private |
| Nishiguchi et al, 2014 [41] | B | + | + | − | Public |
| Shinohara et al, 2013 [42] | B | − | + | − | Not reported |
| Walker et al, 2017 [43] | B | + | + | − | Private |
| Yamada et al, 2012 [44] | B | − | + | − | Public |
| Espinoza et al, 2016 [45] | N/A | N/A | N/A | N/A | Private |
| Kim et al, 2016 [46] | B | + | + | − | Public |
| Twiggs et al, 2018 [47] | N/A | N/A | N/A | N/A | Private |
aNot applicable.
bPatients or health care providers involved in the evaluation but not in the design process.
cAbsent.
dPresent.
ePatients or health care providers involved in both design and evaluation phases.